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Summary Immunoglobulins (Ig) and some complement components (C) were quantified in sera from patients
with gastric carcinoma before surgery and at regular intervals during a 5-year follow-up.
The preoperative concentrations of C1-INH and C4 were higher (P<0.0005 and P<0.005) and IgG lower
(P<0.0005) in 50 patients with recurrence than in 46 5-year survivors. The prognostic significant of Cl-INH
was superior to that of the extent of disease (F-values 37.1 and 26.1). The preoperative immune data classified
76% of the patients correctly as to recurrence and no recurrence. Also, the preoperative C1-INH concentra-
tion had a highly significant effect on time to recurrence of cancer (P= 0.0007), adjusting for age and disease
extent.
After surgery the mean IgG concentrations were within normal range and without difference between the
two groups. On the other hand, the concentrations of Cl-INH and C4 in the individual patients in both
groups remained the same from before to after surgery and throughout the observation period (P = 0.34).
Apparently, the serum levels of C1-INH and C4 do not reflect the bearing of cancer. We therefore suggest
that these variables represent an independent immune state that is appropriate to the host. A comparison of
our variables with those of healthy individuals seems to support this idea. This immune state has a significant
influence on whether a resected gastric cancer will recur, and also on how soon recurrence may be manifest.
Is the altered immune state found in many cancer patients a
consequence of malignancy or rather a state that influences
the growth and spread of cancer? Traditionally, the main
prognosticators of most cancers are the extent of disease at
the time of treatment and the surgical technique. The long-
term outcome within identical groups of patients may never-
theless be widely different, indicating that recurrence of
cancer is regulated by one or more additional factors (Poste
& Fidler, 1980). There is substantial evidence that the prolif-
eration of cancer cells in vitro is affected by various immune
mechanisms (Woodruff, 1982). On the other hand, the effect
of the host's immune state on the growth of cancer in vivo is
not so apparent.
We have studied patients with gastric carcinoma in a
cumulative series starting in 1977. Some humoral immune
factors in sera were quantified preoperatively and at regular
intervals during a 5-year follow-up. Recently we showed that
the preoperative levels of IgG and the complement com-
ponents Cl-inhibitor (CI-INH) and C4 were essential prog-
nosticators of gastric carcinoma and that they were indepen-
dent of the extent of disease (Janssen et al., 1989).
Materials amd methods
Patients
A total of 143 patients with curative intent resection of
gastric carcinoma in the Department of Surgery during the
years 1977-84 were included in this study. Excluded were
patients with other diseases or a history of another malignant
disease within 5 years before gastric cancer surgery. The
mean age (± 1 s.d.) was 67.1 ± 11.2 (range 31-87) years,
median age was 68.0 years, and 38.3% were women. Adjunc-
tive cancer therapy was not administered.
After surgery the patients entered a regular follow-up pro-
gramme with examinations scheduled at every 3 months in
the first year, later at 6-month intervals. The status of the
series 5 years after surgery is shown in Table I.
During the first 5 years after surgery nine patients had a
second primary cancer. Colon cancer appeared in four,
urogenital cancers also in four and squameous cell lung
cancer in one patient.
Twelve patients died from various causes without evidence
of malignant disease at clinical or post-mortem (three
patients) examination. One of them died from complications
after a later laparotomy whereas 11 patients died from car-
diopulmonary or cerebrovascular diseases.
Three patients were lost on follow-up. They are all dead; at
the last follow-up examination 1-3 months before death they
were without signs of malignancy.
Five years after surgery 46 patients were alive and without
clinical signs of disease. During follow-up 50 patients had a
clinical course consistent with recurrence of gastric car-
cinoma. These two groups of patients were compared to each
other and to healthy individuals.
The median time between surgery and clinical signs of
recurrence was 12.3 (range 2-59) months and the median
time between signs of recurrence and death was 2.5 (range
0-34) months.
The age difference between the patients with and without
recurrence was small and insignificant (P>0.05), and there
was no significant sex difference between the groups
(P>0.6). There was also no difference in the surgical proce-
dure for total gastrectomy vs less extensive procedures
(P<0.2) or splenectomy vs no splenectomy (P>0.4).
Healthy individuals
One hundred and ten consecutive healthy individuals from an
annual medical check-up was also used in the study. Individ-
uals with chronic diseases or a history of cancer were ex-
TableI Surveyof143patients5yearsafterpotentiallycurativesurgery
for gastric carcinoma (1977-1984)
No. ofpatients
Alive and clinically cancer-free 46
Clinical course consistent with recurrence 50
Cancer in the vicinity of the resection border 11
Died in hospital after the operation 12
Died later from various causes without evidence of
malignant disease 12
Second primary cancer after gastric cancer surgery 9
Lost to follow-up 3
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cluded. Also excluded were those with an acute disease at the
time of check-up or during the preceding months. The mean
age ( ± 1 s.d.) was 44.6 ± 14.5 (range 20-78) years and 35%
were women.
Pathology
Based on the criteria advised by IUCC (Hermanek & Sobin,
1987), the cancer patients were divided into six groups of
extent of disease at the time of surgery; TINOMO, T2NOMO,
T3NOMO, T2N + MO, T3N + MO, T4NXMO (NX, i.e.
irrespective of lymph nodes). One patient with TIN + MO
disease was assigned to the T2N + MO group. No patients
with distant metastases underwent potentially curative
surgery.
Sera
Concentrations of IgG, IgA and IgM and the complement
components C3, C4 and Cl-INH were quantified in sera as
previously described (Janssen et al., 1987a).
Preoperative blood samples were missing in ten patients,
either because gastric ulcer was the primary diagnosis at the
time of surgery or because they were operated shortly after
admission and before blood was sampled for quantification
of Ig and C.
Statistics
Mean values were compared by Student's t-test, preceded by
Fisher's test for comparison of variances. Distributions of
nominal data were tested in X2 tests with Yates' modification.
The distribution of + and - signs of the differences in
serial observations was tested by the sign test (Lentner,
1982).
The predictive value of the preoperative variables was
assessed by discriminant analysis, performed by the program
7M in BMDP (Jennrich & Sampson, 1990). The groups of
disease extent were ranged in the order 1-6 and entered the
discriminant analysis as an independent variable. The effect
of the variables on time interval from surgery to recurrence
was also tested in a Cox proportional hazard regression
analysis using the program 2L in BMDP (Hopkins, 1990).
Differences between groups of patients in the profile of pre-
and postoperative values of C1-INH were tested in analysis
of variance with repeated measures. The program 5V in
BMDP was used because of an unbalanced design and
incomplete data (Schluchter, 1990).
Results
Preoperative data and extent ofdisease
The mean preoperative serum concentration of IgG was
lower and the concentrations of C4 and C1-INH higher in
patients with recurrence of gastric carcinoma as compared to
the patients alive and disease-free 5 years after surgery (Table
II). The concentration of IgA, IgM and C3 were not different
between the groups.
Discriminant analysis of the preoperative immune variables
classified 76% of the patients correctly as to recurrence.
When the extent of disease, grouped in the order 1-6,
entered the analysis as an independent variable, the correct
classification was 83% (Jackknifed classification). Cl-INH
was the most potent discriminator, followed by extent of
disease, IgG and C4 in that order of significance, Table III.
In addition to the discriminating potential of Cl-INH the
potential of disease extent was considerably less and IgG and
C4 were insignificant. This result was consistent with the
result of a proportional hazard regression analysis using time
to recurrence.
The patients were divided into six groups of Cl-INH
concentrations. The prognosis of patients in each group was
compared to that of the six groups of disease extent, Figure
Table II Preoperative serum concentrations (gl`, mean+ 1 s.d.) of
immunoglobulins and complement components in 43 patients with
recurrence and in 43 patients alive and clinically disease-free 5 years
after potentially curative surgery for gastric carcinoma
Cancer No Significance of
recurrence recurrence differences
IgG 8.91 ± 2.43 11.28±3.57a P<0.0005
IgA 2.35± 1.18 2.25± 1.14 n.s.
IgM 1.35±1.44 1.20±0.61a n.s.
C3 0.90±0.24 0.86±0.15a n.s.
C4 0.43±0.12 0.37±0.11 0.005>P>0.001
Cl-INH 0.43±0.07 0.35±0.07 P<O.0005
aInhomogeneity of variances, Welch's correction applied (Diem &
Lentner, 1982).
1. The risk for recurrence within 5 years after surgery in-
creased evenly both with increasing C1-INH and increasing
extent of disease. In the group of patients with the highest
C1-INH ( > 0.50 gl-'), the recurrence rate was 1.0 as oppos-
ed to 0.78 among the patients with the most advanced
disease.
The patients with recurrence were arbitrarily divided into
three groups, those with recurrence < 8 months, 9-17
months and > 18 months. The preoperative C1-INH concen-
tration was higher where the time interval from surgery to
clinical signs of recurrence was shorter, Figure 2. Moreover,
a proportional hazard regression analysis showed that the
preoperative C1-INH concentration had a highly significant
effect on time to recurrence of cancer (P = 0.0007), adjusting
for age and disease extent. The mean preoperative values in
the three groups of patients with recurrence were 0.48, 0.44
and 0.41 gl-' respectively (and 0.35 gl- 1 for the 5 year sur-
vivors).
On the other hand, there was no clear pattern in the
relation between the groups of disease extent and the time
interval from surgery to signs of recurrence. The median time
interval was at most 18.0 months in the T3NO group and at
least 10.5 months in the T3N + group.
The preoperative data of the patients dying from various
causes without signs of cancer and of the patients with cancer
at the resection border were compared to those of the
patients with and without recurrence. The values could not
be assigned to any of the two groups (Gamel et al., 1986).
Postoperative data
The mean concentrations ofCl-INH and C4 in the groups of
patients with and without recurrence were the same 3 and 6
months after surgery as before surgery, Table IV. The con-
centrations of Cl-INH and C4 preoperatively and 3 months
postoperatively in the individual patients were compared by
the sign test, which was insignificant (P> 0.2). Furthermore,
whenever the first postoperative Cl-INH recording was
> 0.45 gl-', the recurrence rate was 1.0.
The pre- and postoperative Cl-INH in the three groups of
patients with recurrence < 8 months, 9-17 months and > 18
months were compared in an anlaysis of variance model with
Table III The potential (as F-values) of disease extent (ordered in
groups 1-6) and the preoperative concentrations of IgG, C4 and
C1-INH to discriminate between patients with and without recurrence
after potentially curative surgery
Variable F-value Statistical significance
C1-INH 37.07 P<0.001
Disease extent 26.08 P<0.001
IgG 14.61 P<0.001
C4 6.91 0.025>P>0.01
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Figure 2 The mean serum Cl-INH concentrations (g 1-') before
and after surgery in patients with gastric carcinoma, divided into
groups as indicated in the figure. No manifest recurrence at the
time of sampling.
repeated measurements. The between group difference was
highly significant (P<0.0001, between factor). Observations
of clinically disease-free individuals in the respective groups
were few beyond those indicated in Figure 2. Apparently,
C1-INH levels remained unchanged from before to after
surgery and throughout the observation period (P= 0.34,
within factor). Among the long time survivors the mean
Cl-INH concentrations increased slightly and evenly during
the 5-year observation time (Figure 2).
In addition, the postoperative serum concentrations of C4
in each of the three groups of patients with recurrence and
among the long time survivors stayed much at the same
levels as before surgery. There were, however, some varia-
tions at each time interval in the recurrence groups.
Interestingly, discriminant analysis comprising Cl-INH
and C4 as recorded 6 months after surgery classified 71% of
the patients correctly in the recurrence and no recurrence
groups.
In both groups of patients the mean IgG concentrations
were within the normal range after surgery and throughout
the observation period, with no difference between the two
groups. The postoperative concentrations of IgG were inde-
pendent of the preoperative recordings (Table IV).
Healthy individuals
The concentrations of Ig and C are presented in Table V.
There was no difference between the sexes. Some variables
were age dependent as indicated. The variations with age
Table IV Serumconcentrations(gl', mean± 1 s.d.)ofIgG, C4andC1-INH beforeand
3 and 6 months after surgery in patients with and without recurrence within 5 years after
surgery
Three months Six months
Preop. Diff. postop. Diff. postop.
n = 43 n = 26 n = 27
No IgG 11.28±3.57 P<0.001 14.96±4.23 n.s. 14.49± 3.41
recurrence C4 0.37±0.11 n.s. 0.35±0.10 n.s. 0.34±0.08
C1-INH 0.35±0.07 n.s. 0.35±0.05 n.s. 0.35±0.07
With n = 43 n = 31 n = 24
recurrence IgG 8.91±2.43 P<0.001 14.56±3.67 n.s. 13.84±3.14
C4 0.43±0.12 n.s. 0.42±0.11 n.s. 0.41±0.11
Cl-INH 0.43±0.07 n.s. 0.41±0.10 n.s. 0.43±0.10
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Table V Serum concentrations ofimmunoglobulins and complement
components in 110 healthy individuals and the variation with age
Coefficient ofregression
Variable Mean± I s.d. with age P-value
IgG g 1' 12.73±2.49 -0.0207 n.s.
IgMg1' 2.51±1.00 0.0148 0.0464
IgA g I` 1.33±0.61 -0.0108 0.0186
C3 glI' 0.74±0.12 0.0002 n.s.
C4 gl ' 0.35±0.11 0.0017 0.0390
C1-INH glI' 0.35±0.06 0.0025 <0.0001
Mean age of the individuals ± I s.d. = 44.6± 14.5 (range 20-78)
years.
were all linear. Comparison of the healthy individuals with
the cancer patients is invalidated by the age difference
between the groups and the age variation of the variables.
When the data in Table V are extrapolated to the age of the
cancer patients (67 years), the levels of C4 and C1-INH
(C4 = 0.39, C1-INH = 0.41) are in between those of the
recurrence and no recurrence groups of cancer patients as
seen in Table II.
Discussion
In line with a previous report (Janssen et al., 1989) we found
that the preoperative Cl-INH and C4 serum concentrations
were essential and independent prognosticators of gastric
carcinoma. The most significant novel finding in the present
study was how the preoperative levels of these variables
remained unchanged from before to after surgery and
throughout the follow-up period as long as there were no
signs of recurrent disease.
When we found that the preoperative C1-INH and C4
levels were independent of the extent of disease, our idea was
that they represented a prognostic feature appropriate to the
tumour as such or the host in one way or another. As we
now have shown that the levels of Cl-INH and C4 are also
independent of the cancer-bearing state, we suggest that they
represent an immune state appropriate to the host. It is a
state that indicates whether a resected gastric carcinoma will
recur, and also how soon recurrence may be manifest. The
prognostic significance of this state, both as to the risk for
recurrence and for the time lapse until recurrence, surpasses
that of the extent of disease.
One further support for the concept that we are dealing
with a state in the host stems from our previous finding
among patients who presented with a second primary cancer
within 10 years after surgery for gastric carcinoma (Janssen
et al., 1990). These patients had the same immune state
before gastric cancer surgery as the patients with recurrence
of that disease, and in both groups this state was different
from that seen in the long time survivors.
A comparison of Cl-INH and C4 between the cancer
patients and the healthy individuals is uncertain because of
the age difference between the groups and the variation of
the data with age. It seems, nevertheless, that the age
adjusted C4 and C1-INH levels of the healthy individuals are
in between those of the two groups of cancer patients. This
finding may be due to a general heterogeneity in C1-INH and
C4 levels and is in line with our idea that they are tumour
independent variables.
Our finding that the preoperative IgG and C4 gave only
limited or no prognostic information additional to C1-INH is
explained by the correlations between these variables in pre-
operative sera (Janssen et al., 1983). The prognostic signi-
ficance of C4 was slightly weaker than that of C1-INH. This
may be due to variations of C4 with different histological
types of gastric carcinoma (Janssen et al., 1987b).
Contrary to C4 and C1-INH, the mean concentrations of
IgG were within normal range after surgery and without
difference between the groups of patients. This observation
indicates that the low levels of IgG preoperatively is a conse-
quence of the tumour-bearing state (Janssen et al., 1987a;
T0nder & Thunold, 1973; T0nder et al., 1976; 1987). Interest-
ingly, in patients with colorectal carcinoma, IgG varied in the
same way as here from the pre- to the postoperative state
(Shafir et al., 1980; Bjerkeset et al., 1988).
The time interval from clinical signs of recurrence to death
was short in most patients, the median time was 2.5 months.
During this period the patients presented a different immune
pattern compared to the clinically disease-free period, as
previously described (Janssen et al., 1987c). Data obtained at
or after detection of recurrent disease were therefore not
included in the present study.
We think that we are about to identify a state in the host
that regulates the growth and spread of gastric cancer. It has
been shown that the surface of cancer cells is rich in Cl-INH
(Osther & Linnemann, 1973; Osther, 1974; Osther et al.,
1974). Cl-INH may combine with activated Cl and destroy
the protease activity and is believed to cause decay dissocia-
tion of the Cl molecule. It is now 19 years since these
findings were first presented. We are not aware of later
significant publications on the biological consequences of
Cl-INH on the cancer cell surface. We therefore suppose
that the effector mechanisms of the immune state that we
describe may be sought along other paths. The recorded
variations in Cl-INH and C4 levels most probably represent
'the top of the iceberg' as expressions of some essential
humoral or cellular immune mechanisms.
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